Navigation Links
New origin found for a critical immune response
Date:3/1/2009

e scientist who knew about these findings told Gunn the Duke group would "never figure this out" because their findings were so unconventional.

To solve the mystery, the Duke team studied several different types of mice, which were missing other chemokines or chemokine receptors. They found that mice without the Ccr2 chemokine receptor that controls the migration of inflammatory monocytes had much lower accumulation of monocyte-derived dendritic cells and TH1 responses.

The scientists concluded that there is a blood-derived lymph node dendritic cell type that has a key role in developing acute T-cell responses. "For so long, dendritic cells from tissues were the obvious answer," Gunn said. "We found out that that's not always the case."

The team now plans to look at the blood-derived dendritic cells under different conditions to see if they may have other activities. "We observed the activity of these cells after TH1-inducing stimuli, like influenza," Gunn said. "Next we'd like to study other types of immune stimuli to see how the cells respond."

Understanding how dendritic cells stimulate different types of immune response would open the door to enhancing or inhibiting these responses, a major goal of immunologists trying to prevent infections or control autoimmune disease, Gunn said.


'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Comet probes reveal evidence of origin of life, scientists claim
2. Good earth: Brown chemists show origin of soil-scented geosmin
3. Georgia Tech/Emory Center to study origin of life
4. Venous origin of the mammalian lymphatic vasculature
5. St. Jude settles century-old debate on origin of mammalian network of lymphatic vessels
6. The accumulation of sugar in neurons may explain the origin of several neurodegenerative diseases
7. Researchers find origin of breathable atmosphere half a billion years ago
8. New hypothesis for origin of life proposed
9. Hinode: new insights on the origin of solar wind
10. Research pioneer in the developmental origins of psychiatric illness is awarded the Sackler prize
11. Avian origins: new analysis confirms ancient beginnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... VIEW, Calif. , July 7, 2015 /PRNewswire/ ... biometrics market, Frost & Sullivan recognizes Credence ID, ... Sullivan Entrepreneurial Company of the Year Award. ... suite to aid in its mission of offering ... under-recognized populations globally. As Credence ID was formed ...
(Date:7/2/2015)... 2015 Fingerprint Cards has received an ... FPC1155 from the distributor World Peace Industrial Group (WPI), part ... Asia . Deliveries are planned to take ... used by smartphone manufacturers in Asia . ... communicated revenue guidance of approximately 2,200 MSEK for 2015. ...
(Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, a ... with specialties in single use solutions, headquartered in ... Inc. (a California corporation with locations ... San Jose, Costa Rica ). This ... Rica with ATL Technology,s existing facility in ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... Research led by the University of East Anglia ... skeletal muscle development. The finding could have implications ... muscle regeneration in certain diseases, for example cancer and ... and significance of microRNA molecules has only recently been ...
... discovery reveals that the shrimp-like creature at the heart ... role in fertilising the Southern Ocean with iron ... process enhances the ocean,s capacity for natural storage of ... journal Limnology and Oceanography , an international team ...
... Stockholm, Sweden: Ovarian stimulation undertaken by women of advanced ... be disrupting the normal pattern of meiosis a ... cell divisions in the production of oocytes and sperm ... (aneuploidy) that result in IVF failure, pregnancy loss or, ...
Cached Biology News:Crucial role for molecule in muscle development 2Antarctic krill help to fertilize Southern Ocean with iron 2Could ovarian stimulation cause an increase in oocyte chromosome abnormalities? 2Could ovarian stimulation cause an increase in oocyte chromosome abnormalities? 3
(Date:7/28/2015)... DIEGO , July 28, 2015  Kerastem Technologies ... approval from the U.S. FDA Center For Biologics Evaluation ... Therapies to conduct a clinical trial investigating the safety ... of female and early male pattern baldness (androgenic alopecia). ... STYLE trial, follows initial clinical work in ...
(Date:7/28/2015)... 28, 2015 BioStructures, LLC, a privately ... a milestone of 4,000 implantations of Signafuse® Bioactive ... in early 2014 as a bone void filler ... procedures.  This is a distinguished status among recently ... of new synthetic products have received clearance with ...
(Date:7/28/2015)... , July 28, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that it has granted to German life sciences ... development and commercialization of biotechnology (collectively, the "Optionee"), ... oral allogenic tumor vaccine technology (the "Technology"), including ... cancer which is ready to enter a Phase ...
(Date:7/28/2015)... Israel , July 28, 2015 ... a regenerative medicine company utilizing its proprietary plant-based ... that Shomrat Shurtz has been appointed Senior Director ...      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ) , ... of experience in marketing, regulatory and business strategy. ...
Breaking Biology Technology:Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2Revolutionary Bone Graft Exceeds Expectations 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3CollPlant Names Shomrat Shurtz Senior Director of Business Development 2
... Corporation,(NYSE: SYK ) announced that it will host ... p.m., Eastern Time, to discuss the Company,s,operating results for ... an operational update. Operating results for the quarter and ... p.m. that day., Stephen P. MacMillan, President and ...
... in Establishing ... MDRNA as an Independent Company, BOTHELL, Wash., Dec. ... announced today that,it has assigned (i) certain Nastech licenses to ... intellectual,property relates to the development of RNA-based therapeutics, to its,subsidiary, ...
... Inc.,(NYSE: FRX ) and Mylan Inc. (NYSE: ... (nebivolol) was approved by the U.S. Food and Drug,Administration ... once,daily medication that can be used alone or in ... in the U.S. and 65 percent of patients diagnosed ...
Cached Biology Technology:Stryker to Host Conference Call on January 23, 2008 2Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc. 2Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc. 3Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc. 4Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc. 5Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension 2Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension 3Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension 4Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension 5
... Quality ISO 9001:2000 Certified USDA ... Precedures Validated, SOP's Training AALAS ... for All Procedures GLP Documentation Upon Request ... stop shopping point for all your custom ...
...
...
Peptide-affinity Purified Polyclonal Antibody to Sphingolipid Receptor Edg8/S1P5...
Biology Products: